Colorado Dangerous Drugs & Medical Devices

Pradaxa®

Burg Simpson is not currently pursuing new Pradaxa® cases.

Burg Simpson and Seth A. Katz are pleased to announce that Boehringer Ingelheim Pharmaceuticals, Inc. and its related companies agreed to pay $650M to settle nearly 4,000 claims brought on behalf of individuals who were injured after taking Pradaxa®.

PRADAXA® MDL RESULTS IN $650M GLOBAL SETTLEMENT

In May of 2014, Seth A. Katz and Burg Simpson led the Multidistrict Litigation against the manufacturer of Pradaxa® to a successful resolution through a global settlement in which Boehringer Ingleheim paid $650,000,000 to settle approximately 4,500 claims by users of Pradaxa®. The litigation and settlement included a substantial number of wrongful death claims.

Claims against Boehringer Ingleheim, the manufacturer of Pradaxa®, alleged that the drug caused uncontrollable bleeding, causing injuries and death. Pradaxa® is in a class of drugs known as Novel Oral Anti-Coagulants and was approved by the FDA in October of 2010. Pradaxa® was promoted as an alternative to Warfarin (Coumadin) that did not require routing blood monitoring and did not require patients to avoid certain foods that interfere with older anti-coagulants.

In September of 2012, Seth A. Katz was appointed by the Hon. David R. Herndon, U.S. District Court Chief Judge for the Southern District of Illinois, to serve as Co-Lead Counsel in the MDL. The MDL was formed in August of 2012 and the litigation was hard fought at every stage. Burg Simpson was one of a very small number of law firms that led this litigation in every aspect of discovery.

The Plaintiffs’ Steering Committee reviewed tens of millions of pages of documents produced by Boehringer and conducted approximately 50 depositions of current and former Boehringer employees both in the U.S. and in Europe. As Co-Lead Counsel of the Plaintiffs’ Steering Committee, Mr. Katz conducted or participated in approximately half of the depositions. Additionally, the PSC was successful in bringing two sanctions motions against Boehringer for violations of the discovery process, one of which resulted in a fine of close to $1,000,000, which was affirmed by the Seventh Circuit Court of Appeals.
Read the full story here.

BLOOD THINNER PRADAXA® & POTENTIALLY FATAL SIDE EFFECTS

Concern surrounding the safety of Pradaxa® has been growing for some time. In December 2011, the U.S. Food and Drug Administration (FDA) issued a Pradaxa® Safety Announcement, in which the agency confirmed that is was evaluating post-marketing reports of serious bleeding events in patients taking Pradaxa®.

The makers of Pradaxa® are heavily promoting their latest drug as the new and improved alternative to Warfarin—the standard front line therapy for Atrial Fibrillation (AFib) for more than 50 years. Pradaxa® has no known reversal agent. This stands in stark contrast to Warfarin, which can be reversed in the event of an emergency or bleeding event.

Read the FDA Safety Announcement regarding Pradaxa®.

PRADAXA® SIDE EFFECTS

Pradaxa® has been linked to excessive bleeding that can be serious or fatal. Signs or symptoms of serious bleeding may include:

Bleeding that is severe or uncontrollable
Bruises that happen without a known cause or that get larger
Coughing up blood or blood clots
Menstrual or vaginal bleeding that is heavier than normal
Nose bleeding
Pink or brown urine
Red or black stools (looks like tar)
Unusual bleeding from the gums
Vomiting blood or vomit that looks like coffee grounds

In the News

Seth A. Katz speaks on Ring of Fire about Pradaxa®

 January 20, 2021

Arizona Office E-News: January 2021

JANUARY 2021 ARIZONA E-NEWS GOOD LAWYERS Burg Simpson Features: Our Construction Defect Department Our Award -Winning Construction Defect Department is Led by Shareholders Mari Perczak and Craig Nuss Mari Perczak Craig Nuss Burg Simpson’s Construction Defect Department is led by shareholders Craig Nuss and Mari Perczak, who have established reputations in the legal industry. These… Read more »

 January 19, 2021

Burg Simpson Shareholder Angela McGraw Discusses Missed Diagnosis of Birth Defects

Burg Simpson Shareholder Angela McGraw recently published an article with Law Week Colorado on “Presenting Case of Delayed or Missed Diagnosis of Spinal Bifida and Other Serious Birth Defects.” In her article, Ms. McGraw discusses risk factors associated with spina bifida, the failures to diagnose, and when to file a lawsuit. Read the article. About… Read more »

 January 15, 2021

Burg Simpson’s Lawyers Are Trial-Tested and Trial Ready

We Fight for Our Clients’ Rights The practice of law is an endeavor far greater than simply obtaining a law degree. In its most general sense, the practice of law involves providing legal advice to clients, drafting legal documents for clients, and representing clients in legal negotiations and court proceedings. Trial lawyers, however, are the… Read more »

 January 14, 2021

Kerry Jardine Discusses Law Firm Management During COVID-19

The ABA Journal recently published an article by Kerry Jardine that delves into how the pandemic has disrupted normal functioning in the field of law. From closed courtrooms to quarantined clients, the entire industry has been dealing with a new and challenging set of issues. In the article, Mr. Jardine discusses how the management team… Read more »

Denver, CO – Auto Wreck with Injuries on I-70 Blocks Highway

 June 19, 2020

David Hersh: COVID-19 and Loss of Business Income

Shareholder David Hersh Discusses COVID-19 and Loss of Business Income  David P. Hersh is a shareholder and co-practice group leader with  Burg Simpson’s business and commercial litigation department.  “I am David Hersh, Co-leader of the Commercial Litigation Department at Burg Simpson. Business owners across the country have suffered from the loss of business income as… Read more »

David TeSelle Discusses Qui Tam Lawsuits

 June 18, 2020

David TeSelle Discusses Qui Tam Lawsuits

David K. TeSelle is a trial lawyer and co-practice group leader with  Burg Simpson’s business and commercial litigation department.  “Do you have confidential information about a company who is cheating the state or federal government out of money, leaving the American taxpayer holding the bag? If so, there is something you can do about it,… Read more »

 June 16, 2020

Shareholder Jacob Burg Discusses Burg Simpson’s Commitment to Pro Bono Work

Jake Burg is a shareholder and a trial lawyer with  Burg Simpson’s personal injury department. “Since the firm’s inception in 1976, Burg Simpson has been committed to providing pro bono legal services to heroes who have dedicated themselves to serving others in times of great need. As an attorney with Burg Simpson, I was proud to… Read more »

Colorado Springs, CO – Man Injured in Auto Accident on Delta Dr

 June 15, 2020

Injured in a Motorcycle Crash? Call Burg Simpson Now

Injured in a Motorcycle Crash? Call Burg Simpson Now Shareholder Stephen J. Burg is a trial lawyer and the practice group leader of the firm’s personal injury department. If you, or someone you know, has been injured in a motorcycle crash, you need someone to be on your side. Insurance companies make huge profits by… Read more »

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2020 Top 25 Most Influential Lawyers